Related Experiment Videos
Cerebral vasoreactivity in Andeans and headache at sea level
O Appenzeller1, C Passino, R Roach
1NMHEMC Research Foundation, Otto Appenzeller, 361, Big Horn Ridge Drive NE, Albuquerque, NM 87122-1424, USA. ottoarun12@aol.com
Journal of the Neurological Sciences
|March 31, 2004
Summary
High-altitude headache and migraine are common in Cerro de Pasco, Peru. Impaired cerebral vasoreactivity to vasodilators like CO2 and nitric oxide (NO) may contribute to migraine susceptibility in Andean natives.
Area of Science:
- Neurology
- Altitude Medicine
- Physiology
Background:
- Headache and chronic mountain sickness (CMS) are prevalent in Cerro de Pasco, Peru (4338 m).
- Migraine with aura affects 24% of men in this high-altitude population, with frequent attacks.
- Cerebral vasoreactivity is crucial for regulating blood flow in the brain.
Purpose of the Study:
- To investigate cerebral vasoreactivity to CO2 and nitric oxide (NO) in high-altitude natives.
- To compare vasoreactivity at high altitude (Cerro de Pasco) and at sea level (Lima).
- To explore the link between impaired vasoreactivity and migraine in this population.
Main Methods:
- Utilized transcranial Doppler ultrasound to measure middle cerebral artery (MCA) vasoreactivity.
- Assessed response to CO2 rebreathing and isosorbide dinitrate (IDN), an NO donor.
- Measurements were taken in native residents of Cerro de Pasco, including those with CMS, both at altitude and after relocation to Lima (150 m).
Main Results:
- Cerebral vasodilatation in response to both CO2 and NO was found to be defective in Andean natives.
- This impairment was observed both at high altitude and at sea level.
- Incapacitating migraine was associated with impaired cerebral vasoreactivity to these physiologic vasodilators.
Conclusions:
- Defective cerebral vasoreactivity to physiologic vasodilators is a characteristic of Andean natives.
- This impairment may play a role in the susceptibility to migraine.
- Genetic factors influencing endothelial function could underlie susceptibility to migraine.